4.35
price down icon50.34%   -4.41
pre-market  Vorhandelsmarkt:  4.37   0.02   +0.46%
loading

Finanzdaten der Artelo Biosciences Inc-Aktie (ARTL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
37.59%
2.379
3.812 1.195 2.512 2.589
Operating Income/Loss
37.59%
-2.379
-3.812 -1.195 -2.512 -2.589
Nonoperating Income/Loss
79.41%
0.007
0.034 0.063 0.079 0.106
Income/Loss From Continuing Operations Before Tax
85.06%
-2.372
-15.87 -1.132 -2.433 -2.483
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
85.06%
-2.372
-15.87 -1.132 -2.433 -2.483
Net Income/Loss
85.06%
-2.372
-15.87 -1.132 -2.433 -2.483
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
100.00%
-
-12.10 - - -
Diluted Average Shares
32,710%
3.281
0.01 3.228 - -
Diluted Earnings Per Share
38.46%
-0.72
-1.17 -0.35 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):